Investing.com’s stocks of the week

Go back to Investing.com’s stocks of the week

Yorkville Ives on Meta Platforms Inc. (META): 'the Street is still underestimating its growth potential in our view'

October 26, 2026 8:42 AM EDT

Yorkville Ives analyst Dan Ives reiterated an Outperform rating and $920.00 price target on Meta Platforms Inc. (NASDAQ: META).

The analyst comments "The Street should not be surprised. The new Class C is a funding lever, and management said on the 3Q26 call that it adds financing flexibility while preserving voting control and that it had no specific plans yet; five days later it does. Meta generated $97 billion of operating cash flow through the first three quarters of 2026, but capex... More

Citi reiterates sell rating on Moderna with $80 price target

October 26, 2026 6:38 AM EDT

Citi analyst Geoff Meacham reiterated a Sell rating and $80.00 price target on Moderna (NASDAQ: MRNA).

Meacham said Moderna's ESMO investor call focused on the potential of intismeran, with management and participating key opinion leaders emphasizing its neoantigen-specific immune response, efficacy across melanoma risk... More